Nagarro releases audited financial statements and annual report for FY 2025, reaffirms the preliminary numbers
Revenue of €999 million (+2.8%) represents 6.1% constant currency growth;Gross profit of €321 million…
CONCEPT MEDICAL ANNOUNCES PRELIMINARY 3-YEAR SIRONA DATA AT CHARING CROSS SYMPOSIUM 2026
LONDON, April 27, 2026 /PRNewswire/ -- Concept Medical Inc., today announced the…
Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6$9.7 Million, Up 3-4% Year-over-Year
Sanuwave is pleased to announce preliminary revenues of $9.6 million to $9.7…
Wix Announces Preliminary Results of Modified Dutch Auction Tender Offer
NEW YORK, April 2, 2026—Wix.com Ltd. (Nasdaq: WIX) (“Wix” or the “Company”)…
Inventiva reports preliminary 2025 fiscal year financial results
Cash and cash equivalents at €99.3 million, and €131.6 million in short-term…
Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces…
Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026
Exceeding latest 2025 guidance following a strong performance from both commercial arms…
Mawson Infrastructure Group Inc. Releases Preliminary Unaudited Results for Fourth Quarter and Fiscal Year 2025
Company Reaches Settlements in Two Separate Pending Litigation Cases to Resolve Large…
FY 2025 Preliminary and Unaudited Figures Highlighting Significant Progress in the Execution of the Genesis Plan
Press Release FY 2025 Preliminary and Unaudited Figures Highlighting Significant Progress in…
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
January 13, 2026 07:05 ET | Source: Sight Sciences, Inc. MENLO PARK,…
